CClinicalTrials.gg
Status unknownNCT01707589Updated Feb 12, 2013

Noninvasive Monitoring of Vital Signs in Neonates

A Phase 2 interventional study of The new sensor is not on the market. We have named it Elfi-sensor. in Admission to the NICU and Need for Physiological Monitoring., sponsored by Meir Medical Center. Status unknown at 1 site in Israel. Open to participants aged 1 Day to 6 Months. Per ClinicalTrials.gov, last updated 2013-02-12.

Sponsored by Meir Medical Center · Phase 2, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Feb 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
1 Day to 6 Months
Sex
All
01

Study summary

the investigators are assessing a non-invasive monitor based on dynamic light scattering that measures pulse rate and respiration rate. The monitor also will be equipped with a temperature sensor and a motion sensor. This monitor will allow multi-parametric measurements in neonates in a simple and noninvasive manner.

Read the detailed description

Monitoring vital signs in neonates is important. This currently is done with multiple standard clinical monitors. the investigators are developing a very small (coin-sized) sensor that can measure pulse rate, respiratory rate, temperature and body motion. the investigators propose to test our sensor against standard monitoring techniques in neonates in a neonatal ICU (NICU).

The monitor, called ELFI-monitor, is based on dynamic light scattering. A low-power laser beams light into the skin, and the red blood cells in the underlying skin return the light which is recorded in a light sensor. The movement of the red blood cells is affected by the rhythmic cardiac contractility. in this manner, heart rate and rhythm can be assessed. The ELFI monitor also contains an embedded temperature probe and a miniature 3-D motion sensor, allowing capture of additional parameters.

Methods:

the investigators plan to study 100 neonates admitted to the NICU of Meir Hospital Center. These infants are routinely monitored with standard equipment including ECG, oximeter, temperature, and respiratory monitors. the investigators will simultaneously monitor these children with the ELFI monitor, recording pulse rate, cardiac rhythm, respiratory rate, skin temperature and body motion. Recordings will be conducted for a one-hour period on each subject. Data recordings from the ELFI sensor will be compared to the readouts of the conventional monitors used on the patient. It is important to emphasize that the data recordings of the ELFI sensor will not affect clinical decisions in any manner, but will merely be recorded for comparison with conventional sensors.

02

Conditions studied

  • Admission to the NICU and Need for Physiological Monitoring.

Keywords

  • monitoring
  • heart rate
  • respiration rate
  • temperature
  • motion
  • noninvasive
  • physiologic parameters
  • NICU
03

In context

Lead sponsor

Meir Medical Center is the lead sponsor of 389 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All neonates admitted the Meir Hospital center NICU
  • Parents provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Neonates with skin disease
05

Study design

Phase
Phase 2
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Neonates admitted to the NICU

    Neonates admitted to the NICU for a variety of medical reasons will be the cohort group. Those whose parents give informed consent will compose the subjects of the study

    Device: The new sensor is not on the market. We have named it Elfi-sensor.

Interventions

  • DeviceThe new sensor is not on the market. We have named it Elfi-sensor.

    Participating subjects will be monitored for one hour with a noninvasive sensor.The noninvasive sensor, the size of a penny, will be affixed to the skin, above the umbilicus, with pediatric adhesive tape. The monitor will record continuously the heart rate, cardiac rhythm, respiratory rate and body motion.

06

What researchers measure

Primary outcomes

  1. Comparison of data collected from ELFI sensor to standard monitors

    the investigators are comparing the data recoded by the new sensor to that recorded by conventional sensors during a period of one hour in the NICU. The data recorded by the new sensor will not be used for clinical decision making.

    Time frame: 6 months

07

Study locations

1 site
  • Neonatal department Meir Medical Center
    Kfar Saba, Israel
    • Sofia Bauer-rosek, MD · Contact · bauers@clalit.org.il · 09-7471554
    • Sofia Bauer-rosek, MD · Principal investigator
08

References and documents

Related links

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01707589
Lead sponsor
Meir Medical Center
Responsible party
Sponsor
First posted
Oct 16, 2012
Start date
May 2013
Primary completion
Oct 2014 (estimated)
Last update
Feb 12, 2013

Study contacts

Sofia Bauer-rosek, MD
principal investigator · Meir Medical Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion